Adzenys Xr-odt Tablet, Orally Disintegrating
Product Images NDC 70165-025

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Adzenys Xr-odt (NDC 70165-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neos Therapeutics Brands, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Adzenys Xr Odt 1)

Chemical structure of amphetamine showing a benzene ring attached to a two-carbon chain with an amino group and a methyl group on the second carbon.*

FDA Label Image

Figure 1 (Adzenys Xr Odt 2)

A pharmacokinetic line graph showing mean plasma concentration (ng/mL) over time (hours) for Dextroamphetamine and Levoamphetamine from two formulations: Amphetamine XR-ODT and MAS ER. The graph compares concentration levels up to 60 hours post-dose, with distinct symbols and lines differentiating each drug and formulation.*

FDA Label Image

Adzenys Xr-odt 3.1 mg (Adzenys Xr Odt 3)

Packaging label for Adzenys XR-ODT 3.1 mg orally disintegrating tablets by Neos Therapeutics Brands, LLC. The label indicates the product is amphetamine extended-release, with 30 tablets (5 blister cards of 6 tablets each) in a travel case. Instructions include not to crush or chew tablets and to dispense the enclosed Medication Guide with the product.*

FDA Label Image

Adzenys Xr-odt 6.3 mg (Adzenys Xr Odt 4)

Packaging label for Adzenys XR-ODT 6.3 mg, amphetamine extended-release orally disintegrating tablets. The label shows the product name, strength, dosage form, and instructions such as 'Do not crush or chew tablets.' It includes manufacturer information for Neos Therapeutics Brands, LLC, and states the package contains 30 tablets (5 x 6-count blister cards) in a travel case.*

FDA Label Image

Adzenys Xr-odt 9.4 mg (Adzenys Xr Odt 5)

Packaging label for Adzenys XR-ODT 9.4 mg extended-release orally disintegrating tablets containing amphetamine, manufactured by Neos Therapeutics Brands, LLC. The label shows the product name, strength, dosage form, NDC 70165-015-30, and usage instructions including a warning not to crush or chew tablets. The package contains 30 tablets in five 6-count blister cards with a travel case.*

FDA Label Image

Adzenys Xr-odt 12.5 mg (Adzenys Xr Odt 6)

Label for Adzenys XR-ODT 12.5 mg tablets, amphetamine extended-release orally disintegrating tablets. The packaging includes the product name, strength, dosage form, and labeler Neos Therapeutics Brands, LLC. The label also shows the NDC 70165-020-30 and directions for pharmacists to dispense the medication guide. The packaging specifies 30 tablets in blister cards inside a travel case.*

FDA Label Image

Adzenys Xr-odt 15.7 mg (Adzenys Xr Odt 7)

Packaging label for Adzenys XR-ODT 15.7 mg, an amphetamine extended-release orally disintegrating tablet by Neos Therapeutics Brands, LLC. The label includes dosage strength, product and manufacturer information, NDC 70165-025-30, and instructions for pharmacists to dispense the enclosed Medication Guide. The package contains 30 tablets (5 blister cards of 6 tablets each).*

FDA Label Image

Adzenys Xr-odt 18.8 mg (Adzenys Xr Odt 8)

Adzenys XR-ODT 18.8 mg extended-release orally disintegrating tablets packaging label. The box displays the product name, strength, and formulation prominently, including cautions such as 'Do not crush or chew tablets.' It contains 30 tablets in blister cards within a travel case. The labeler is Neos Therapeutics Brands, LLC. NDC 70165-030-30 is shown on the packaging.*

FDA Label Image

3.1 mg Tablet Bottle (Adzenys Xr Odt 9)

Label for Adzenys XR-ODT 3.1 mg extended-release orally disintegrating tablets containing amphetamine. The label specifies the dosage form, strength, and includes storage instructions at controlled room temperature with a warning not to crush or chew tablets. The label shows the manufacturer as Neos Therapeutics Brands, LLC and indicates a package count of 30 tablets.*

FDA Label Image

6.3 mg Tablet Bottle (Adzenys Xr Odt 10)

Label for Adzenys XR-ODT 6.3 mg orally disintegrating tablets by Neos Therapeutics Brands, LLC. The label states the active ingredient as amphetamine extended-release, warns not to crush or chew tablets, and indicates a package size of 30 tablets. Storage instructions and a medication guide note are included.*

FDA Label Image

9.4 mg Tablet Bottle (Adzenys Xr Odt 11)

Label for Adzenys XR-ODT 9.4 mg orally disintegrating extended-release tablets by Neos Therapeutics Brands, LLC. The label includes dosage warnings, storage instructions, and states each tablet contains 9.4 mg of amphetamine. The package contains 30 tablets and is for Rx only.*

FDA Label Image

12.5 mg Tablet Bottle (Adzenys Xr Odt 12)

Label for Adzenys XR-ODT 12.5 mg orally disintegrating extended-release tablets containing amphetamine. The label includes dosage instructions, storage conditions at 20°C to 25°C, and a warning not to crush or chew the tablets. The package contains 30 tablets. The labeler is Neos Therapeutics Brands, LLC, Denver, CO.*

FDA Label Image

15.7 mg Tablet Bottle (Adzenys Xr Odt 13)

Label for Adzenys XR-ODT 15.7 mg orally disintegrating tablets by Neos Therapeutics Brands, LLC. It specifies the active ingredient amphetamine extended-release, tablet strength of 15.7 mg, and packaging containing 30 tablets. The label includes warnings against crushing or chewing the tablets and storage instructions to keep in a cool, dry place between 20°C to 25°C.*

FDA Label Image

18.8 mg Tablet Bottle (Adzenys Xr Odt 14)

Label for Adzenys XR-ODT 18.8 mg orally disintegrating tablets, an amphetamine extended-release product by Neos Therapeutics Brands, LLC. The label includes dosage warnings, storage instructions, and states that each tablet contains 18.8 mg amphetamine equivalent from mixed salts. The package contains 30 tablets and advises not to crush or chew the tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.